Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Paris, France
Countries of investment
  • France
  • Germany
Investment stages
  • Seed
Industries
  • Fintech
  • AI
  • Health Tech
  • Blockchain
About
Kurma Partners is a key European venture capital group specializing in healthcare and biotechnology, with a strong focus on transforming scientific discoveries into cutting-edge medical solutions for severe diseases.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Kurma Partners is a major player in the funding of healthcare and biotechnology in Europe, investing at various stages of maturity, from company creation to capital expansion.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in private equity, the fund manager has executed over 50 transactions primarily in the technology and healthcare sectors across Europe and North America. Emphasizing a thematic investment approach, their portfolio reflects a strong focus on innovation-driven companies at growth and expansion stages. Notable exits include several successful IPOs and strategic sales, showcasing a data-driven methodology that balances operational expertise with market insights. Their strategic style prioritizes operator-first investments, ensuring alignment with management teams to drive value creation.

Kurma Partners Contacts Information

Primary contact

Secondary contact

Team

Thierry Laugel

Sylvain Cascarino

Remi Droller

Philippe Peltier

Hadrien Bouchez

Benjamin Belot

Alain Horvais

SA£Â©GolA£Â¨Ne Perin

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp